Pathogens composition and antibiotic resistance of non-immunocompromised patients with hospital acquired pneumonia and ventilator-associated pneumonia

WANG Ling-wei,WU Wei-yuan,CHEN Dan-dan,QIU Chen
DOI: https://doi.org/10.13381/j.cnki.cjm.2012.06.020
2012-01-01
Abstract:Objective To investigate the clinical features,pathogens composition,antibiotic resistance of non-immunocompromised patients with hospital acquired pneumonia(HAP) or ventilator-associated pneumonia(VAP) in order to guide clinical antibiotics use.Method 46 non-immunocompromised patients with HAP or VAP diagnosed by a prospective surveillance were retrospectively reviewed.Result The average onset duration was 14.3±13.2 days after admission and the most common underlying diseases were cerebrovascular disease(16/46),chronic lung disease(13/46) and diabetes mellitus(5/46).The positive culture rate was 58.7%,with Acinetobacter baumannii(8/27),Pseudomonas aeruginosa(6/27),Enterobacter cloacae(3/27) and Staphylococcus aureus(3/27) being leading pathogens.80.4% of patients had been priscribed antibiotics within 72 hours after admission.Cephalosporins(29/46),Carbapenems(9/46) and Glycopeptides(5/46) were the most commonly used antibiotics as initial treatment.A.baumannii were intermediate to cefoperazone/sulbatam with MIC>32 mg/L and resistant to all other drugs.2 isolates of P.aeruginosa were highly resistant to meropenem with MIC=128 mg/L.Conclusion HAP or VAP of non-immunocompromised patients is prone to occur in gerontal patients with cerebrovascular diseases or chronic lung diseases.The leading pathogens of HAP are multidrug-resistant A.baumannii and P.aeruginosa with high antibiotics resistance to carbapenem.We shall optimize the initial antibiotics use in HAP/VAP treatment.
What problem does this paper attempt to address?